TrialArteriosclerosis, thrombosis, and vascular biology2014

Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.

Maria J Gutierrez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.